Mmp13 gene downregulation in the Myd88KO tumor group could be attributed to the fact that the MMP13 protumor activity may be mediated through the MyD88/ERK/NF-κB signaling pathway [48,49,50]. The gene discussed is MMP13; the disease is neoplasm.